VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,239 | -61.3% | 239 | +1.3% | 0.00% | – |
| Q2 2023 | $5,789 | +8.2% | 236 | +2.6% | 0.00% | – |
| Q1 2023 | $5,352 | -8.1% | 230 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $5,821 | -75.7% | 230 | -81.3% | 0.00% | -50.0% |
| Q3 2022 | $24,000 | -22.6% | 1,230 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $31,000 | -3.1% | 1,230 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $32,000 | -38.5% | 1,230 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $52,000 | -64.4% | 1,230 | -63.3% | 0.00% | -70.0% |
| Q3 2021 | $146,000 | +43.1% | 3,350 | +55.8% | 0.01% | +42.9% |
| Q2 2021 | $102,000 | – | 2,150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |